AAIC 2025 Abstract·26 DecAssessment Tools for DS‐AD: Global Expert Perspectives on Utility and AppropriatenessStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·23 DecEvaluating the Feasibility of a Personalized Endpoint in Down Syndrome‐associated Alzheimer’s Disease: Inventory‐facilitated Goal Attainment ScalingStudy in peopleBiomarkersPaper